01 QUESTION SET.docx

01 QUESTION SET W81K02-20-Q-0128

QUESTION #1.

Could you please provide annual volumes for the tests listed?

ANSWER #1

· TB Interferon Gamma Release (IGRA) assay – 2500 tests

· Measles IgG – 2200 tests

· Mumps IgG – 2200 tests

· Rubella IgG – 2000 tests

· VZV IgG – 4000 tests

· Rubella IgM – 0 at present but considering for future patient needs

· CMV IgG/IgM – 0 at present but considering for future patient needs

· Toxoplasma IgG/IgM – 0 at present but considering for future patient needs

· HSV-1/2 IgG – 0 at present but considering for future patient needs

QUESTION #2

What level of automation is the lab looking for in relation to price?

ANSWER #2

The long answer is it depends on the technical capability (batching vs. random access, no. of batches at once). If you need a metric, we are looking at needing enough automation to dedicate 0.25 FTE to the required annual testing listed below (See Answer #1). That allows us to work within our existing staffing constraints and bring on the testing. That cannot be achieved if each test must be batched and run separately requiring a technician to run back-to-back runs.

** The Statement of Work (Paragraph 5. SPECIFIC TASKS) lists the Salient Characteristics that will be used for the Technical Evaluation of all offers.